| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |